Learn about the global COVID-19 drug-associated APIs market through The Business Research Company, which provides information on COVID-19 drug-associated APIs market size, COVID-19 drug-associated APIs market drivers and restraints, COVID-19 drug-associated APIs market players, the COVID-19 impact on the COVID-19 drug-associated APIs market, and more.

The global COVID-19 drug associated APIs market size is expected to grow from $5.55 billion in 2021 to $5.99 billion in 2022 at a compound annual growth rate (CAGR) of 7.9%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The COVID-19 drug associated APIs market is expected to reach $7.55 billion in 2026 at a CAGR of 6%.

The increasing demand for antivirals, antimalarials, and bronchodilators is projected to boost the demand for COVID-19 associated drug APIs market over the forecast period.

Request A Sample For The Global COVID-19 Drug Associated APIs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3248&type=smp

The COVID-19 drug-associated APIs market consists of sales of active pharmaceutical ingredients used in the manufacturing of COVID-19 drugs. The active pharmaceutical ingredients are chemicals which are responsible for pharmacological activity in the human body and are used as a base in pharmaceutical drug or medicine. The APIs used for the preparation of COVID-19 drugs and include Azithromycin, Fentanyl, Albuterol, Cisatracurium and others.

Global COVID-19 Drug-Associated Apis Market Segments Include:

By Drug Class: Antimalarials, Bronchodilators, Antibiotics, Antivirals, Others

By Synthesis Type: Synthetic, Biotech

By Business Mode: Captive API, Merchant API

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America is the largest region in the COVID-19 drug-associated APIs market in 2021.

Key players operating in the pharmaceutical industry that manufactures COVID-19 drug associated APIs are focusing on strategies such as plant capacity or production capacity expansion to meet the increasing demand due to the rising number of coronavirus cases across the globe.

TBRC’s COVID-19 drug-associated APIs market report covers:

Major Market Players: Dr. Reddy’s Laboratories, Lianyungang Guike Pharmaceutical, Alembic Pharmaceutical, Wockhardt Ltd, Sandoz Srl, Lupin Limited, Aurobindo Pharma Ltd., Shanghai Shyndec Pharmaceutical (Haimen) Co Ltd, and Yatai Pharma

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The COVID-19 Drug Associated APIs Global Market Report 2022 –Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides COVID-19 drug-associated APIs market overviews, analyses and forecasts market size, share, COVID-19 drug-associated APIs market players, COVID-19 drug-associated APIs market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s COVID-19 drug-associated APIs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Remdesivir Global Market Report 2022

COVID-19 Detection Test Kits And Consumables Global Market Report 2021

COVID-19 Rapid Test Kits Global Market Report 2021

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: